Caption Management, LLC - BIOHAVEN PHARMACTL HLDG CO L ownership

BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 330 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q2 2022. The put-call ratio across all filers is 0.46 and the average weighting 1.1%.

Quarter-by-quarter ownership
Caption Management, LLC ownership history of BIOHAVEN PHARMACTL HLDG CO L
ValueSharesWeighting
Q2 2022$5,944,000
-89.9%
40,800
-91.8%
0.08%
-88.4%
Q1 2022$58,914,000
-20.0%
496,900
-7.1%
0.71%
-14.2%
Q4 2021$73,677,000
+169.9%
534,600
+172.1%
0.83%
+163.9%
Q3 2021$27,296,000
+49.1%
196,500
+4.2%
0.31%
+31.0%
Q2 2021$18,303,000
+2025.8%
188,500
+1396.0%
0.24%
+1157.9%
Q1 2021$861,000
-98.4%
12,600
-98.0%
0.02%
-98.5%
Q4 2020$54,693,000
+249.8%
638,106
+165.3%
1.25%
+240.7%
Q3 2020$15,635,000
-68.1%
240,500
-64.1%
0.37%
-77.6%
Q2 2020$48,969,000
+513.8%
669,816
+185.8%
1.63%
+261.6%
Q1 2020$7,978,000
-83.8%
234,352
-74.2%
0.45%
-72.8%
Q4 2019$49,370,000
+32.0%
906,900
+1.1%
1.66%
-14.7%
Q3 2019$37,406,000
+73.9%
896,600
+82.6%
1.95%
+79.7%
Q2 2019$21,507,000
+87.0%
491,100
+119.8%
1.08%
+70.8%
Q1 2019$11,498,000223,4000.63%
Other shareholders
BIOHAVEN PHARMACTL HLDG CO L shareholders Q2 2022
NameSharesValueWeighting ↓
RP Management, LLC 2,111,111$144,294,00054.16%
Knoll Capital Management, LLC 856,844$58,565,00038.16%
ORACLE INVESTMENT MANAGEMENT INC 2,123,271$145,126,00021.73%
KINGDON CAPITAL MANAGEMENT, L.L.C. 860,261$58,799,0006.01%
ARS Investment Partners, LLC 561,442$38,375,0004.46%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 176,400$12,057,0003.19%
Eventide Asset Management 2,015,000$137,725,0002.04%
Avidity Partners Management LP 1,049,800$71,754,0001.98%
SILVERARC CAPITAL MANAGEMENT, LLC 50,089$3,424,0001.87%
Nicholas Investment Partners, LP 375,654$25,676,0001.79%
View complete list of BIOHAVEN PHARMACTL HLDG CO L shareholders